Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, Maryland
- Most recent report
- 8-K, filed Oct 19, 2026
- Incorporated
- Delaware
- Filings on record
- 233 filings
- On EDGAR
- CIK 1795091
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 10
News 8 of 41
Prospectuses and Registrations 8 of 28
- S-8 Registration statement for an employee plan Sep 21, 2026
- 424B5 Prospectus supplement for an offering Aug 21, 2026
- 424B5 Prospectus supplement for an offering Aug 6, 2026
- 424B5 Prospectus supplement for an offering Apr 2, 2026
- S-8 Registration statement for an employee plan Oct 31, 2025
- 424B5 Prospectus supplement for an offering Aug 25, 2025
- 424B3 Prospectus supplement for an offering Aug 25, 2025
- S-3 Shelf registration statement Aug 8, 2025
Proxies 8 of 9
- DEFA14A Extra proxy material Jul 24, 2026
- DEF 14A Proxy statement for a shareholder vote Jul 24, 2026
- DEFA14A Extra proxy material Oct 17, 2025
- DEFA14A Extra proxy material Aug 25, 2025
- DEF 14A Proxy statement for a shareholder vote Aug 25, 2025
- PRE 14A Preliminary proxy statement Aug 15, 2025
- DEFA14A Extra proxy material Apr 2, 2025
- DEF 14A Proxy statement for a shareholder vote Feb 28, 2025
Ownership 8 of 60
- 3 Insider reported their initial holding Oct 5, 2026
- 3 Insider reported their initial holding Oct 5, 2026
- 3 Insider reported their initial holding Jul 23, 2026
- 5/A Insider reported deferred transactions, amended May 15, 2026
- 4 Insider reported a trade Feb 13, 2026
- 4 Insider reported a trade Feb 13, 2026
- 4 Insider reported a trade Feb 13, 2026
- 4 Insider reported a trade Feb 13, 2026
Other 8 of 85
Everything here comes from OS Therapies Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.